IJCOPE Journal

UGC Logo DOI / ISO Logo

International Journal of Creative and Open Research in Engineering and Management

A Peer-Reviewed, Open-Access International Journal Supporting Multidisciplinary Research, Digital Publishing Standards, DOI Registration, and Academic Indexing.
Journal Information
ISSN: 3108-1754 (Online)
Crossref DOI: Available
ISO Certification: 9001:2015
Publication Fee: 599/- INR
Compliance: UGC Journal Norms
License: CC BY 4.0
Peer Review: Double Blind
Volume 02, Issue 6

Published on: June 2026

REVOLUTIONIZING DRUG DISCOVERY: THE EVOLVING ROLE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING

Harikrishna Bommala

Department of Computer Science and Engineering/ KG Reddy College of Engineering and Technology / University, Hyderabad, India

Article Status

Plagiarism Passed Peer Reviewed Open Access

Available Documents

Abstract

The recent surge in artificial intelligence and machine learning has been noteworthy. It has decreased the workload of humans significantly enhanced the quality of life. The article explains the application of artificial intelligence and machine learning in supporting drug discovery and drug development to make them efficient and accurate. In the present study, a systematic review of studies was conducted; these were identified based on earlier knowledge of the authors and keyword search in easily accessible databases which were filtered according to related context, abstract, methodology, and full text. This collection of work substantiated the role of machine learning and artificial intelligence in making drug development and drug discovery processes cost-effective or entirely eliminating clinical trials, due to the facilitation of the simulation process through these technologies. They also made it possible for researchers to investigate various molecules more comprehensively, without trials. The findings of the paper illustrate the common application of machine learning and artificial intelligence techniques in drug discovery, and point towards a bright future for these technologies; these findings should allow researchers, students, and the pharmaceutical industry to explore machine learning and artificial intelligence further in a drug discovery and development environment.

How to Cite this Paper

Bommala, H. (2026). Revolutionizing Drug Discovery: The Evolving Role of Artificial Intelligence and Machine Learning. International Journal of Creative and Open Research in Engineering and Management, <i>02</i>(6). https://doi.org/10.55041/ijcope.v2i6.120

Bommala, Harikrishna. "Revolutionizing Drug Discovery: The Evolving Role of Artificial Intelligence and Machine Learning." International Journal of Creative and Open Research in Engineering and Management, vol. 02, no. 6, 2026, pp. . doi:https://doi.org/10.55041/ijcope.v2i6.120.

Bommala, Harikrishna. "Revolutionizing Drug Discovery: The Evolving Role of Artificial Intelligence and Machine Learning." International Journal of Creative and Open Research in Engineering and Management 02, no. 6 (2026). https://doi.org/https://doi.org/10.55041/ijcope.v2i6.120.

Search & Index

References

[1].      Rantanen J, Khinast J. The future of pharmaceutical manufacturing sciences. J Pharm Sci 2015;104(11):3612–38. doi:10.1002/jps.24594.

[2].       Greenhill AT, Edmunds BR. A primer of artificial intelligence in medicine. Tech Innov Gastrointest Endosc 2020;22(2):85–9. doi:10.1016/j.tgie.2019.150642.

[3].       Solanki P, Baldaniya D, Jogani D, et al. Artificial intelligence: new age of transformation in petroleum upstream. Pet Res 2021. doi:10.1016/j.ptlrs.2021.07.002.

[4].       Kshirsagar A, Shah M. Anatomized study of security solutions for multimedia: deep learning-enabled authentication, cryptography and information hiding. Adv Secur Solut Multimed 2021. doi:10.1088/978-0-7503-3735-9CH7.

[5].       Anthony CC. Big data in medicine: the upcoming artificial intelligence. Prog Pediatr Cardiol 2016;43:91–4. doi:10.1016/j.ppedcard.2016.08.021.

[6].       Göller AH, Kuhnke L, Montanari F, et al. Bayer’s in silico ADMET platform:a journey of machine learning over the past two decades. Drug Discov Today 2020;25(9):1702–9. doi:10.1016/j.drudis.2020.07.001.

[7].       Abu-Elezz I, Hassan A, Nazeemudeen A, et al. The benefits and threats of blockchain technology in healthcare: a scoping review. Int J Med Inform 2020;142:104246. doi:10.1016/j.ijmedinf.2020.104246.

[8].       Park BJ, Choi HJ, Moon SJ, et al. Pharmaceutical applications of 3D printing technology: current understanding and future perspectives. J Pharm Investig 2018;49(6):575–85. doi:10.1007/S40005-018-00414-Y.

[9].       Zimmerling A, Chen X. Bioprinting for combating infectious diseases. Bioprinting 2020;20:e00104. doi:10.1016/j.bprint.2020.e00104.

[10].Elbadawi M, Gaisford S, Basit AW. Advanced machine-learning techniques in drug discovery. Drug Discov Today 2021;26(3):769–77. doi:10.1016/j.drudis.2020.12.003.

Ethical Compliance & Review Process

  • All submissions are screened under plagiarism detection.
  • Review follows editorial policy.
  • Authors retain copyright.
  • Peer Review Type: Double-Blind Peer Review
  • Published on: Jun 11 2026
CCBYNC

This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. You are free to share and adapt this work for non-commercial purposes with proper attribution.

View License
Scroll to Top